Medication-interaction evidence is incomplete. Antidepressants and other psychiatric medicines may alter effects, while combinations involving lithium or medicines that affect seizure risk deserve particular caution. Do not change prescribed treatment without the prescriber.
Key facts
What the evidence supports
- 1Absence of a documented interaction is not proof of safety.
- 2Individual medication, dose, diagnosis, and timing matter.
- 3A clinician or pharmacist is the correct source for personal medication decisions.
Evidence quality
What can and cannot be concluded
Definitions, pharmacology, and documented community practices
Some basic mechanisms and commonly described practices are documented. That does not establish a consumer treatment effect.
Clinical outcomes from repeated low doses
Controlled microdosing studies remain limited, with mixed or null findings and meaningful expectation effects.
Medication-interaction evidence is incomplete. Antidepressants and other psychiatric medicines may alter effects, while combinations involving lithium or medicines that affect seizure risk deserve particular caution. Do not change prescribed treatment without the prescriber.
Common questions
Answered without a universal protocol
Do SSRIs always block psilocybin?+
No. Effects may be altered or blunted for some people, but the interaction is not predictable enough for a universal rule.
Can I stop medication before trying psilocybin?+
Do not stop or taper prescribed medication without the prescriber. Withdrawal and relapse can be serious.
Does “no known interaction” mean safe?+
No. Interaction research is incomplete, especially for repeated low-dose use.
Product-format context
Product descriptions, laboratory documentation, fulfillment policies, and client support remain on iMicrodosing.com. Deeper research remains on iMicrodosing.org.
Educational information only. Not medical advice. 21+ only.